BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8561493)

  • 1. Purification of a phenobarbital-inducible UDP-glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation.
    Oguri K; Kurogi A; Yamabe K; Tanaka M; Yoshisue K; Ishii Y; Yoshimura H
    Arch Biochem Biophys; 1996 Jan; 325(2):159-66. PubMed ID: 8561493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a phenobarbital-inducible morphine UDP-glucuronyltransferase isoform, absent from Gunn rat liver.
    Ishii Y; Tsuruda K; Tanaka M; Oguri K
    Arch Biochem Biophys; 1994 Dec; 315(2):345-51. PubMed ID: 7986077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a morphine UDP-glucuronyltransferase isoform from untreated rat liver.
    Ishii Y; Oguri K; Yoshimura H
    Biol Pharm Bull; 1993 Aug; 16(8):754-8. PubMed ID: 8220321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
    Styczynski P; Green M; Puig J; Coffman B; Tephly T
    Mol Pharmacol; 1991 Jul; 40(1):80-4. PubMed ID: 1906977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids.
    Coffman BL; Rios GR; Tephly TR
    Drug Metab Dispos; 1996 Mar; 24(3):329-33. PubMed ID: 8820424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1.
    Ishii Y; Takami A; Tsuruda K; Kurogi A; Yamada H; Oguri K
    Drug Metab Dispos; 1997 Feb; 25(2):163-7. PubMed ID: 9029046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and purification of two human liver UDP-glucuronosyltransferases.
    Irshaid YM; Tephly TR
    Mol Pharmacol; 1987 Jan; 31(1):27-34. PubMed ID: 3100939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital.
    Bock KW; Josting D; Lilienblum W; Pfeil H
    Eur J Biochem; 1979 Jul; 98(1):19-26. PubMed ID: 111930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation, purification and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes.
    Falany CN; Tephly TR
    Arch Biochem Biophys; 1983 Nov; 227(1):248-58. PubMed ID: 6416180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and purification of rat liver morphine UDP-glucuronosyltransferase.
    Puig JF; Tephly TR
    Mol Pharmacol; 1986 Dec; 30(6):558-65. PubMed ID: 3097500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of UDP-glucuronyltransferase from kidney microsomes of beta-naphthoflavone-treated rat.
    Yokota H; Ohgiya N; Ishihara G; Ohta K; Yuasa A
    J Biochem; 1989 Aug; 106(2):248-52. PubMed ID: 2509439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of 4-hydroxybiphenyl UDP-glucuronyltransferase from bovine liver microsomes.
    Kanehara H; Yokota H; Sato M; Yuasa A
    J Biochem; 1992 Nov; 112(5):578-82. PubMed ID: 1478915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase.
    Roy Chowdhury J; Roy Chowdhury N; Falany CN; Tephly TR; Arias IM
    Biochem J; 1986 Feb; 233(3):827-37. PubMed ID: 3085655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.
    Miyauchi Y; Kurita A; Yamashita R; Takamatsu T; Ikushiro S; Mackenzie PI; Tanaka Y; Ishii Y
    Biochem Biophys Res Commun; 2020 Apr; 525(2):348-353. PubMed ID: 32093886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate.
    de Sandro V; Catinot R; Kriszt W; Cordier A; Richert L
    Biochem Pharmacol; 1992 Apr; 43(7):1563-9. PubMed ID: 1567478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
    Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
    Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A procedure for the rapid separation and purification of UDP-glucuronosyltransferases from rabbit liver microsomes.
    Tukey RH; Robinson R; Holm B; Falany CN; Tephly TR
    Drug Metab Dispos; 1982; 10(2):97-101. PubMed ID: 6124411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucuronidation of morphine by dog liver microsomes: identification of morphine-6-O-glucuronide.
    King C; Finley B; Franklin R
    Drug Metab Dispos; 2000 Jun; 28(6):661-3. PubMed ID: 10820138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.
    Kurita A; Miyauchi Y; Ikushiro S; Mackenzie PI; Yamada H; Ishii Y
    J Pharmacol Exp Ther; 2017 May; 361(2):199-208. PubMed ID: 28228532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.